KRM Ayurveda (KRMAYURVED)
Score breakdown: P/E: 0/3 · ROCE: 2/2 · Growth: 0/2 · Dividend: 0/1
Key Financials
| Current Price | ₹222.85 |
| Market Cap | ₹429.57 Cr |
| P/E Ratio | 35.5 |
| ROCE | 41.83% |
| ROE | —% |
| Dividend Yield | 0% |
| Profit Growth | 0% |
| Debt/Equity | — |
| Sales Growth | 0% |
| Promoter Holding | 69.15% |
| 52-Week Range | ₹173 — ₹343.95 |
| Sector | Pharmaceuticals & Biotechnology |
AI Analysis
AI-generated, general educational analysis — not personal investment advice.
When I look at KRM Ayurveda, I see a business with some attractive fragments but not a complete mosaic. A promoter holding of 69.15% is good; I like owners with skin in the game. A ROCE of 41.83% is genuinely impressive — if it can be sustained, it suggests the Ayurveda business earns well on invested capital. The latest quarter shows ₹48 Cr of sales and ₹8 Cr of net profit, so there is real economic activity underneath the shares.
The full AI analysis, bull and bear case and key monitorables are in FairStock Pro.
Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer